Cargando…

Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario

Background: After the bioresorbable PLLA-based vascular scaffold (Absorb BVS) was taken from the market due to its high adverse event rates, a magnesium-based scaffold (Magmaris) was introduced. Objective: To compare the acute performance of the sirolimus-eluting magnesium alloy Magmaris scaffold wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boeder, Niklas F., Dörr, Oliver, Koepp, Tim, Blachutzik, Florian, Achenbach, Stephan, Elsässer, Albrecht, Hamm, Christian W., Nef, Holger M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236697/ https://www.ncbi.nlm.nih.gov/pubmed/34195239 http://dx.doi.org/10.3389/fcvm.2021.696287

Ejemplares similares

Clinical presentation does not affect acute mechanical performance of the Novolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography
por: Boeder, Niklas F., et al.
Publicado: (2021)

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds
por: Boeder, Niklas F., et al.
Publicado: (2019)

First case report of fully robotically assisted lithotripsy in heavily calcified left main stenosis
por: Hofmann, Felix J, et al.
Publicado: (2022)

Serial invasive imaging follow‐up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)

Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population
por: Al Nooryani, Arif, et al.
Publicado: (2022)

Magnesium Bioresorbable Scaffold (BRS) Magmaris vs Biodegradable Polymer DES Ultimaster in NSTE-ACS Population—12-Month Clinical Outcome
por: Rola, Piotr, et al.
Publicado: (2022)

Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds
por: Włodarczak, Adrian, et al.
Publicado: (2021)

The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome
por: Włodarczak, Adrian, et al.
Publicado: (2021)

Mid-term safe and effective profile of the Magmaris scaffold in percutaneous coronary intervention: a prospective, single-center study
por: Truong, Binh Quang, et al.
Publicado: (2023)

Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort
por: Włodarczak, Adrian, et al.
Publicado: (2023)

Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents
por: Rola, Piotr, et al.
Publicado: (2021)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
por: Peng, Xiang, et al.
Publicado: (2020)

Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations
por: Schochlow, Katharina, et al.
Publicado: (2021)

Second-generation robotic angioplasty system use for the treatment of ST-elevation myocardial infarction: a first-in-man proof of concept case report
por: Hofmann, Felix J, et al.
Publicado: (2023)

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
por: Gori, Tommaso, et al.
Publicado: (2019)

Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials
por: Liu, Yong, et al.
Publicado: (2022)

Very late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy
por: Karanasos, Antonios, et al.
Publicado: (2014)

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
por: Pahmeier, Kathrin, et al.
Publicado: (2022)

Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis
por: Wan, Yan-di, et al.
Publicado: (2022)

Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios
por: Jaguszewski, Milosz, et al.
Publicado: (2014)

Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020
por: Gaede, Luise, et al.
Publicado: (2022)

Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry
por: Bossard, Matthias, et al.
Publicado: (2022)

BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients
por: Verheye, Stefan, et al.
Publicado: (2020)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

In vitro performance of Lifetech IBS Angel™ (iron-based bioresorbable scaffold) stents during overdilation for use in pediatric patients
por: Bjorkman, Kurt, et al.
Publicado: (2022)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

Topochemical control in desolvation of coordination polymers
por: Lusi, Matteo
Publicado: (2015)

Desolvation Processes in Channel Solvates of Niclosamide
por: Mann, Jen E., et al.
Publicado: (2023)

Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience
por: Özel, Erdem, et al.
Publicado: (2016)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Unveiling the self-association and desolvation in crystal nucleation
por: Li, Danning, et al.
Publicado: (2021)

Bioresorbable scaffolds in the treatment of coronary artery disease
por: Zhang, Yaojun, et al.
Publicado: (2013)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

In vivo degradation and endothelialization of an iron bioresorbable scaffold
por: Lin, Wenjiao, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020)

Thrombosis and myocardial infarction: the role of bioresorbable scaffolds
por: Leesar, Massoud A., et al.
Publicado: (2023)

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis
por: Goncalves-Ramírez, Luis R., et al.
Publicado: (2019)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
por: Cakal, Beytullah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h27hfk8shc16becujb050i1tno